Emcure Pharmaceuticals Gets Sebi's Go-Ahead To Float IPO

[email protected]12 Jan, 2022News

Bain Capital-backed Emcure Pharmaceuticals has received capital markets regulator Sebi's go-ahead to raise funds through an initial share-sale. The initial public offering (IPO) comprises fresh issuance of equity shares worth Rs 1,100 crore and offer of sale (OFS) of 18,168,356 equity shares by promoters and existing shareholders, according to the draft red herring prospectus (DRHP).